FDA's thumbs up for Prenosis' AI for sepsis: a game-changer?
In a landmark development poised to reshape the landscape of medical diagnostics, the U.S. Food and Drug Administration (FDA) has officially sanctioned Prenosis' pioneering artificial intelligence (AI) tool designed for the early detection of sepsis.
United States Greg Bullington Srinivasan Ramanujam Johns Hopkins University Sepsis Immunoscore Magnolia Medical Technologies
Source: outsourcing-pharma.com